CRISPR-U™ has been successfully applied inmore than 100 types of cell lines. The high efficiency of this exclusive technology

can easily achieve knockout(KO), point mutation(PM), and knockin(KI), making Ubigene a industry-leading company

 home and abroad.

Hurry up, take advantage of our best offer ever!

Limited Offers for 2020 : From July 1st to August 31th

We have been cooperated with noble clients from more than 20 countriesand 100 cities in Europe, Asia and North America.

Ubigene has alsoestablished offices in the United States, France and Hong Kong, which enablesour products to reach every

corner of the world.

CRISPR-U™ is an exclusive technologyindependently developed by Ubigene Bioscience for gene editing cell lines.

Byoptimizing gene editing vectors and processes, the efficiency in gene-cuttingand recombination of CRISPR-U™ is

10 times higher than the conventional CRISPR/Cas9 technology. CRISPR-U™ can easily achieve knockout(KO),

 pointmutation(PM), and knockin(KI) in cell lines. Ubigene has been successfully appliedthis innovation in more than

100 types of cell lines. We are capable of customizing genetically-modified liver cell lines as you desireand satisfying

 various needs in gene editing.